Proposed Rules. Notice
135 words·~1 min read·
/register/2002/03/01/02-5043A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Cancellation AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is canceling the meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee scheduled for March 12, 2002. The meeting was announced in the **Federal Register** of February 7, 2002 (67 FR 5831). FOR FURTHER INFORMATION CONTACT: Thomas H. Perez, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6758, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12542. Dated: February 26, 2002. Linda A. Suydam, Senior Associate Commissioner for Communications and Constituent Relations. [FR Doc. 02-5043 Filed 2-27-02; 11:19 am]